z-logo
Premium
Vardenafil, a clinically available phosphodiesterase inhibitor, potentiates the killing effect of EGCG on CLL cells
Author(s) -
Kumazoe Motofumi,
Tsukamoto Shuntaro,
Lesnick Connie,
Kay Neil E.,
Yamada Koji,
Shanafelt Tait D.,
Tachibana Hirofumi
Publication year - 2015
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.13135
Subject(s) - cd19 , medicine , antigen , immunology , cd38 , cancer research , microbiology and biotechnology , biology , stem cell , cd34 , genetics

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom